Table 1B.

Observed post-COVID-19 cancer diagnostic activity (Cancer Wait Times), 1 April 2020–31 January 2021

	Observed rate	Expected rate	Percentage reduction (95% CI)	Estimated no. missing from England population, to three significant digits (95% CI)
Event rate per 100 000 patient-months
First consultant appointments following urgent referral from primary care	296	366	19.2 (19.1 to 19.3)	398 000 (395 000 to 401 000)
Incidence rate per 100 000 patient-months
First treatments for new cancer from the urgent primary care referral pathway	21.4	25.5	16.1 (15.5 to 16.8)	23 300 (22 200 to 24 400)
First treatments for new cancer from the national screening pathway	1.63	3.47	53.2 (52 to 54.3)	10 400 (10 000 to 10 900)
First treatments for new cancer	39.7	47.4	16.3 (15.9 to 16.6)	43 600 (42 500 to 44 700)